Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2014-05-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
NCT02852057
Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma
NCT03966560
Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients
NCT02053298
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00333125
24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination
NCT00972257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Latanoprost
solution, 1 drop of 50ug/ml latanoprost, was given to study eye after washout period of 1 week between drugs
Latanoprost
1 drop of latanoprost was given to study eye after washout period of 1 week between drugs
Timolol
solution, 1 drop of 5mg/ml timolol , was given to study eye after washout period of 1 week between drugs
Timolol
1 drop of timolol was given to study eye after washout period of 1 week between drugs
dorzolamide
solution, 1 drop of 20 mg/ml dorzolamide, was given to study eye after washout period of 1 week between drugs
Dorzolamide
1 drop of dorzolamide was given to study eye after washout period of 1 week between drugs
Other
no drug given and pupil measurements were performed before and at 30 and 180 min at equivalent hours as drugs measurements
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Latanoprost
1 drop of latanoprost was given to study eye after washout period of 1 week between drugs
Timolol
1 drop of timolol was given to study eye after washout period of 1 week between drugs
Dorzolamide
1 drop of dorzolamide was given to study eye after washout period of 1 week between drugs
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* systemic disease
* smoking
* refractive error \>= 6 diopters
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glostrup University Hospital, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birgit Sander
md
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik Lund-Andersen, Professor
Role: STUDY_DIRECTOR
Head of the project
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glostrup University Hospital
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GlostrupUH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.